2017
Tetanus in adults: results of the multicenter ID-IRI study
TOSUN, S., A. BATIREL, A.I. OLUK, F. AKSOY, E. PUCA et. al.Základní údaje
Originální název
Tetanus in adults: results of the multicenter ID-IRI study
Autoři
TOSUN, S. (792 Turecko), A. BATIREL (792 Turecko), A.I. OLUK (792 Turecko), F. AKSOY (792 Turecko), E. PUCA (8 Albánie), F. BENEZIT (250 Francie), S. URAL (792 Turecko), S. NAYMAN-ALPAT (792 Turecko), T. YAMAZHAN (792 Turecko), V. KOKSALDI-MOTOR (792 Turecko), R. TEKIN (792 Turecko), E. PARLAK (792 Turecko), P. TATTEVIN (250 Francie), K. KART-YASAR (792 Turecko), R. GUNER (792 Turecko), A. BASTUG (792 Turecko), M. MERIC-KOC (792 Turecko), S. ONCU (792 Turecko), A. SAGMAK-TARTAR (792 Turecko), A. DENK (792 Turecko), F. PEHLIVANOGLU (792 Turecko), G. SENGOZ (792 Turecko), S.M. SORENSEN (208 Dánsko), G. CELEBI (792 Turecko), Lenka FAŠANEKOVÁ (703 Slovensko, garant, domácí), H. GEDIK (792 Turecko), S. DIRGEN-CAYLAK (792 Turecko), A. ESMAOGLU (792 Turecko), S. EROL (792 Turecko), Y. CAG (792 Turecko), E. KARAGOZ (792 Turecko), A. INAN (792 Turecko) a H. ERDEM (792 Turecko)
Vydání
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, NEW YORK, SPRINGER, 2017, 0934-9723
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30303 Infectious Diseases
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 2.537
Kód RIV
RIV/00216224:14110/17:00097325
Organizační jednotka
Lékařská fakulta
UT WoS
000406290100014
Klíčová slova anglicky
tetanus
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 7. 3. 2018 16:15, Soňa Böhmová
Anotace
V originále
Tetanus is an acute, severe infection caused by a neurotoxin secreting bacterium. Various prognostic factors affecting mortality in tetanus patients have been described in the literature. In this study, we aimed to analyze the factors affecting mortality in hospitalized tetanus patients in a large case series. This retrospective multicenter study pooled data of tetanus patients from 25 medical centers. The hospitals participating in this study were the collaborating centers of the Infectious Diseases International Research Initiative (ID-IRI). Only adult patients over the age of 15 years with tetanus were included. The diagnosis of tetanus was made by the clinicians at the participant centers. Izmir Bozyaka Education and Research Hospital's Review Board approved the study. Prognostic factors were analyzed by using the multivariate regression analysis method. In this study, 117 adult patients with tetanus were included. Of these, 79 (67.5%) patients survived and 38 (32.5%) patients died. Most of the deaths were observed in patients >60 years of age (60.5%). Generalized type of tetanus, presence of pain at the wound area, presence of generalized spasms, leukocytosis, high alanine aminotransferase (ALT) and C-reactive protein (CRP) values on admission, and the use of equine immunoglobulins in the treatment were found to be statistically associated with mortality (p < 0.05 for all). Here, we describe the prognostic factors for mortality in tetanus. Immunization seems to be the most critical point, considering the advanced age of our patients. A combination of laboratory and clinical parameters indicates mortality. Moreover, human immunoglobulins should be preferred over equine sera to increase survival.